#VisualAbstract: Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
Tag: lung cancer
Osimertinib associated with longer overall survival versus comparator EGFR-TKIs
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
Lung cancer screening according to existing guidelines is likely cost-effective
1. In this study comparing three prominent lung cancer screening strategies, all were found to be cost-effective, yielding incremental cost-effectiveness ...
Life-gained-based selection for cancer screening may result in superior health outcomes compared to risk-based selection
1. In this modelling study, life-gained-based selection of smokers for lung cancer screening resulted in a nearly threefold greater gain ...
LUNG-RADS criteria increases positive predictive value for lung cancer detection in high-risk patients [Classics Series]
The following study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Radiology: Summaries of Clinically Relevant ...
Prediction tool helps tailor lung cancer screening to patient benefit and preferences
1. Prediction tool may help physicians better personalize screening discussions with patients. 2. Benefits of the prediction tool, low-dose computer ...
Risk-based lung cancer screening may prevent more deaths than current guidelines
1. In terms of early lung cancer death per individual screened, targeting lung cancer mortality risk may improve lung cancer ...
Osimertinib improves progression-free survival in EGFR-mutated non-small-cell lung cancer: The FLAURA trial
1. Osimertinib demonstrated a significantly longer duration of progression-free survival compared to standard of care epidermal growth factor receptor (EGFR)-tyrosine ...
2 Minute Medicine Rewind June 26, 2017
First-line nivolumab in stage IV or recurrent non-small-cell lung cancer Platinum-based combination chemotherapy has long been used in the first-line ...
Non-malignant extrapulmonary findings common in lung cancer screening program
1. In a retrospective review of over 17 000 patients in the National Lung Screening Trial (NLST), there was a ...
